Farmak, the leader in the domestic pharmaceutical market, has expanded the Lamicon antifungal line with a new drug product, Lamicon Dermgel. The new drug is produced in the form of a gel (15 g).
Lamicon Dermgel is an antifungal agent in the form of a gel with a broad spectrum of action and a short course of treatment. It helps to eliminate one of the major symptoms of fungal skin infection – itching.
The drug is recommended for the treatment of skin infections caused by dermatophytes (tinea corporis, tinea cruris, tinea pedis) and tinea versicolor.
The main feature of the new drug is its cooling effect and antipruritic action.
Now the Lamicon antifungal portfolio has three dosage forms for topical use: Lamicon cream, Lamicon spray, Lamicon Dermgel, and also Lamicon in tablet form.
Training will start for more than 100 students who have signed up, and every student wishing to attend training sessions may join them. While attending the Eco-School, the students will gain the current knowledge about energy saving, climate changes, biodiversity, and interrelations in nature through the tabletop and active environmental games. They w...
According to “Business” magazine, JSC “Farmak” is ranked among the TOP 5 companies of Ukraine in the nomination “Strong Top Management – Dream Team”. The foundation of strong and modern business is its staff component. People, their development, professionalism are the core values of “Farmak”. “We have more than 2500 employees. We fill more than […]
According to the decision of economic courts of all instances (2009-2010), the name “Corvalol” (“Corvalolum”) was used exclusively by one manufacturer as the name of the medicinal product. Information that Corvalol was manufactured by 70 pharmaceutical enterprises of the USSR is not true. In the middle of 20th century, Lomonosov Kyiv Chemical and Pharmaceuti...